Infection fatality risk for SARS-CoV-2 in community dwelling population of Spain: nationwide seroepidemiological study
Roberto Pastor‐Barriuso(Instituto de Salud Carlos III), Marina Pollán(Instituto de Salud Carlos III), Mayte Pérez‐Olmeda(Instituto de Salud Carlos III), Jose L Sanmartín(Ministry of Health), Juan F Muñoz-Montalvo(Ministry of Health), Beatriz Pérez‐Gómez(Instituto de Salud Carlos III), Amparo Larrauri(Instituto de Salud Carlos III), Raquel Yotti(Instituto de Salud Carlos III), Jesús Oteo(Instituto de Salud Carlos III), José León Paniagua(Instituto de Salud Carlos III), Miguel A. Hernán(Harvard University), Nerea Fernández de Larrea, Israel Cruz(Instituto de Salud Carlos III), Concepción Delgado-Sanz(Instituto de Salud Carlos III), Mariano Martín(Ministry of Health), Aurora Fernández-García, Faustino Blanco(Ministry of Health), Inmaculada León-Gómez(Instituto de Salud Carlos III)
Cited by 191
Related Papers
Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies
|BMJ|2017|1.8k
Vitamin D intake and incidence of multiple sclerosis
|Neurology|2004|1.1k
Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US
|JAMA Internal Medicine|2020|1k
Observational Studies Analyzed Like Randomized Experiments
|Epidemiology|2008|814
Activated Injectable Vitamin D and Hemodialysis Survival
|Journal of the American Society of Nephrology|2005|784